These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8016417)

  • 1. Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications.
    Arnett FC
    Rheum Dis Clin North Am; 1994 May; 20(2):371-90. PubMed ID: 8016417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of the HLA-B27 test in rheumatic diseases. A current perspective.
    Khan MA
    Arch Intern Med; 1980 Feb; 140(2):177-80. PubMed ID: 6986127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of the HLA phenotype in inflammatory rheumatic diseases].
    Saraux A; Guedes C; Allain J; Devauchelle V; Valls I; Baron D; Youinou P; Le Goff P
    Presse Med; 1997 Jun; 26(22):1040-4. PubMed ID: 9246112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HLA system and collagen diseases (author's transl)].
    Bueno M; Pérez-González J; Sarria A
    An Esp Pediatr; 1981 Jul; 15(1):13-22. PubMed ID: 6797335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis.
    Maksymowych WP; Suarez-Almazor ME; Buenviaje H; Cooper BL; Degeus C; Thompson M; Russell AS
    J Rheumatol; 2002 Nov; 29(11):2319-26. PubMed ID: 12415587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
    Flatø B; Lien G; Smerdel A; Vinje O; Dale K; Johnston V; Sørskaar D; Moum T; Ploski R; Førre Ø
    J Rheumatol; 2003 Feb; 30(2):386-93. PubMed ID: 12563700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hitherto assembled results with the assessment of HLA antigens in rheumatic diseases and their impact.
    Dostál C; Ivasková E; Tesárek B; Hána I
    Czech Med; 1979; 2(1-2):56-63. PubMed ID: 316761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis.
    Moroldo MB; Donnelly P; Saunders J; Glass DN; Giannini EH
    Arthritis Rheum; 1998 Sep; 41(9):1620-4. PubMed ID: 9751094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA serological and class II genotyping in sarcoidosis patients in Japan.
    Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
    Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HL-A antigens in clinical medicine.
    Bluestone R
    Dis Mon; 1976 Oct; 23(1):1-27. PubMed ID: 1086197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis.
    Nepom GT; Gersuk V; Nepom BS
    J Rheumatol Suppl; 1996 Mar; 44():5-9. PubMed ID: 8833044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human major histocompatibility complex: the HLA system].
    Charron D; Khalil I
    Rev Prat; 1994 Jan; 44(1):20-7. PubMed ID: 8178053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles.
    Murray KJ; Moroldo MB; Donnelly P; Prahalad S; Passo MH; Giannini EH; Glass DN
    Arthritis Rheum; 1999 Sep; 42(9):1843-53. PubMed ID: 10513798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis.
    Frankenberger B; Breitkopf S; Albert E; Scholz S; Keller E; Schattenkirchner M; Weiss EH; Kellner H
    J Rheumatol; 1997 May; 24(5):899-903. PubMed ID: 9150078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [B27-positive diseases. A new concept in rheumatology (author's transl)].
    Schattenkirchner M; Krüger K; Herzer P
    MMW Munch Med Wochenschr; 1980 Nov; 122(48):1725-8. PubMed ID: 6779137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of rheumatic diseases: tests and traps.
    Schmidt MC
    Hosp Pract (Off Ed); 1984 Sep; 19(9):82E-82G, 82K, 82O passim. PubMed ID: 6432827
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic aspects of ankylosing spondylitis.
    Khan MA; Ball EJ
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):675-90. PubMed ID: 12406434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA and association with illness].
    Wegener S
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):213-9. PubMed ID: 7919911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive genetic screening for type-1 diabetes in the Hungarian population].
    Hermann R; Soltész G
    Orv Hetil; 2004 Feb; 145(7):337-42. PubMed ID: 15049049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.